Qmetrics Technologies
Private Company
Funding information not available
Overview
Qmetrics Technologies operates at the intersection of digital health and AI, providing advanced medical image analysis services and software. Its core offerings include clinical trial imaging support through a centralized core lab and a proprietary platform, Kuvia3D, which transforms 2D MRI scans into quantifiable 3D models for applications in sports medicine, neurology, and oncology. The company combines decades of team expertise in musculoskeletal radiology and imaging science with AI-driven radiomics to detect subtle patterns invisible to conventional radiology, aiming to improve clinical trial efficiency and diagnostic insight. It serves as a specialized service provider to the life sciences industry while also developing its own diagnostic indices.
Technology Platform
Proprietary radiomics and AI software (Kuvia3D) that transforms 2D medical images into quantifiable 3D models, extracting subtle patterns and textures for advanced analysis.
Opportunities
Risk Factors
Competitive Landscape
Qmetrics competes in the clinical trial imaging core lab space against large CROs (like IQVIA, Parexel) and specialized imaging CROs (like BioClinica, Calyx). In the AI-radiomics software arena, it faces numerous AI-focused medtech startups (e.g., Aidoc, Zebra Medical) and the AI divisions of major imaging equipment manufacturers (GE, Siemens, Philips), all vying to turn imaging data into actionable diagnostic insights.